ClinicalTrials.Veeva

Menu

Novel Therapy of PAD by Combined Transplantation of BMCs

H

Heinrich-Heine University, Duesseldorf

Status and phase

Unknown
Phase 1

Conditions

Peripheral Arterial Disease

Treatments

Procedure: intraarterial and intramuscular injection of BMCs

Study type

Interventional

Funder types

Other

Identifiers

NCT00411840
TAM-PAD

Details and patient eligibility

About

We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.

After 2 and 13 months walking distance and perfusion indices were monitored.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • severe limb ischemia

Exclusion criteria

  • infectious disease
  • cancer

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Bartsch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems